← FDA Drug Approvals (Drugs@FDA)

HYFTOR

NDA · New Drug Application · Sponsor: NOBELPHARMA · Approved 2022-03-22

Drug application

FDA Application #

NDA213478

Application type

New Drug Application

Brand name

HYFTOR

Generic name

SIROLIMUS

Active ingredients

SIROLIMUS

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

NOBELPHARMA

Manufacturer

Nobelpharma America, LLC

First approval

2022-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown